Second-Line Therapies After Treatment with Fludarabine, Cyclophosphamide, and Rituximab (FCR) or Fludarabine and Cyclophosphamid Alone (FC) for Chronic Lymphocytic Leukemia (CLL) within the CLL8-Protocol of the German CLL Study Group (GCLLSG)

Details

Database :

OAIster

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1252544519

Document Type :

Electronic Resource